Blue Cross Blue Shield of Vermont Selects MedeAnalytics' Medical Management Analytics

Published on:

EMERYVILLE, Calif., April 30, 2013 -- MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Blue Cross Blue Shield of Vermont (BCBSVT) selected MedeAnalytics' Medical Management Analytics. BCBSVT's vision is to provide population health management--which includes an integrated approach to physical and mental health--as well as future episode-based contracting, also known as bundled payments.

"We selected MedeAnalytics to increase our effectiveness in clinical analytics and predictive modeling based on the strong capabilities of their software system and their expert support for effective implementation," said Robert Wheeler, M.D., vice president and chief medical officer of BCBSVT.

"This will help us identify additional opportunities to improve healthcare and will generate timely metrics for clinical projects. These advanced analytic tools will be particularly valuable in our rapidly changing healthcare environment."

"We are pleased to expand our relationship with BCBSVT and continue to show value in healthcare cost containment," said MedeAnalytics Senior Vice President and General Manager, Health Plan Solutions Scott Paddock. "They are leading the way of improving healthcare through analytics and transparency."

About Blue Cross and Blue Shield of Vermont
Blue Cross and Blue Shield of Vermont is the state's oldest and largest private health insurer, providing coverage for about 180,000 Vermonters. It employs over 340 Vermonters at its headquarters in Berlin and branch office in South Burlington, and offers group and individual health plans to Vermonters. More information about Blue Cross and Blue Shield of Vermont is available on the internet at www.bcbsvt.com. Blue Cross and Blue Shield of Vermont is an independent corporation operating under a license with the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield Plans.

About MedeAnalytics
Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.